PRMT1 and cancer: Further studies have also identified overexpression of PRMT1 in some cancers, including leukemia, prostate, esophageal, lung, bladder, and breast compared to normal cells leading to increased protein levels and promoting cell proliferation (5, 17, 18, 19).